{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-004747","form_type":"8-K","ticker":"TVRD","cik":"0001346830","company_name":"Tvardi Therapeutics, Inc.","filed_at":"2025-01-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.402506+00:00","generated_at":"2026-05-27T21:58:12.929894+00:00","sec_items":["7.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"low","headline":"Cara Therapeutics files investor presentation for proposed merger with Tvardi","bullets":["Furnishes investor presentation (Exhibit 99.1) for post-combination company with Tvardi, a STAT3-targeted fibrosis biopharma.","Merger announced Dec 17, 2024; pending regulatory and shareholder approvals; S-4 filed with preliminary proxy/prospectus.","Presentation is being shared with potential investors; no new financial terms or deal value disclosed in filing.","Forward-looking statements reference efforts to regain Nasdaq compliance on stockholders' equity requirement."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-004747","json":"https://secwatch.observer/filing/0001104659-25-004747.json","markdown":"https://secwatch.observer/filing/0001104659-25-004747.md","text":"https://secwatch.observer/filing/0001104659-25-004747.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1346830/000110465925004747/0001104659-25-004747-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1346830/000110465925004747/tm253758d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T21:58:12.929894+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}